CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 834 enrolled
Drug / intervention
Other: Retrospective chart review; one participant encounter visit.other
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT01285076
NCT01285076N/ACompleted

Naturalistic Evaluation of Hypoglycemic Events in Diabetic Subjects (NEEDS Study)

Merck Sharp & Dohme LLC·observational·Posted Jan 27, 2011·Updated May 21, 2024

In Brief

An observational study evaluating Other: Retrospective chart review; one participant encounter visit. for Type 2 Diabetes Mellitus. Completed, enrolled 834 participants across 1 site.

Detailed Summary

This is a multi-center, observational, retrospective and cross-sectional study to be conducted in a cohort of consecutively selected participants with Type 2 diabetes mellitus (DM) who have been treated with sulphonylurea (SU) monotherapy or SU + metformin (MF) combination therapy by their cardiologist, nephrologist, neurologist, or family practice doctor for at least 6 months prior to Study Enrollment.

Study Details

Study Typeobservational
Allocation--
Masking--
Primary Purpose--
CountriesTaiwan
Collaborators--

Timeline

N/ACompletedFinished
2011201220132014201520162017201820192020202120222023202420252026
First PostedJan 27, 2011
Enrollment StartJan 10, 2011
Primary CompletionDec 27, 2012
TodayJul 2, 2026
Enrollment to primary: 2.0 yearsPosted 15.4 years ago

Interventions

Other: Retrospective chart review; one participant encounter visit.other

Participants will be selected based on medical record review in the office of their treating cardiologist, nephrologist, neurologist, or family practice doctor. Participants will have one encounter visit to fill out questionnaires and have a blood draw and recording of weight, blood pressure and waist circumference.